About the Company
We do not have any company description for Certara, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CERT News
Certara, Inc. (CERT)
PRINCETON, N.J., April 16, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara Cloud, the unifying ...
Certara Announces New Corporate Headquarters in Radnor
RADNOR – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the relocation of ...
Certara Inc Ordinary Shares
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Certara Inc (700.BE)
PRINCETON, N.J., April 16, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara Cloud, the unifying ...
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
PRINCETON, N.J., April 16, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara Cloud, the unifying platform ...
Analyst Scoreboard: 4 Ratings For Certara
Stay up to date on Certara analyst ratings. About Certara Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and ...
Decoding 4 Analyst Evaluations For Certara
Stay informed and make data-driven decisions with the assistance of our Ratings Table. Certara Inc accelerates medicines to patients using biosimulation software and technology to transform ...
Certara, Inc.'s (NASDAQ:CERT) Intrinsic Value Is Potentially 66% Above Its Share Price
The projected fair value for Certara is US$29.68 based on 2 Stage Free Cash Flow ... 53% higher than Certara's analyst price target of US$19.38 How far off is Certara, Inc. (NASDAQ:CERT) from its ...
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
PRINCETON, N.J., April 16, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara Cloud, the unifying ...
Loading the latest forecasts...